Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
AstraZeneca
Fish and Richardson
Harvard Business School
Chubb
Medtronic
US Army
Cerilliant
Farmers Insurance
Merck

Generated: August 20, 2017

DrugPatentWatch Database Preview

Tripelennamine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for tripelennamine hydrochloride and what is the scope of tripelennamine hydrochloride patent protection?

Tripelennamine hydrochloride
is the generic ingredient in three branded drugs marketed by Nylos, Watson Labs, Novartis, Parke Davis, Anabolic, Barr, Lannett, Impax Labs, and Heather, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for tripelennamine hydrochloride.

Summary for Generic Name: tripelennamine hydrochloride

Tradenames:3
Patents:0
Applicants:9
NDAs:14
Drug Master File Entries: see list1
Bulk Api Vendors: see list40
Clinical Trials: see list2,259
Patent Applications: see list831
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:tripelennamine hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis
PBZ
tripelennamine hydrochloride
TABLET;ORAL083149-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
TRIPELENNAMINE HYDROCHLORIDE
tripelennamine hydrochloride
TABLET;ORAL085188-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Anabolic
TRIPELENNAMINE HYDROCHLORIDE
tripelennamine hydrochloride
TABLET;ORAL083037-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Impax Labs
TRIPELENNAMINE HYDROCHLORIDE
tripelennamine hydrochloride
TABLET;ORAL080785-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
TRIPELENNAMINE HYDROCHLORIDE
tripelennamine hydrochloride
TABLET;ORAL080790-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Fuji
QuintilesIMS
Mallinckrodt
Harvard Business School
Federal Trade Commission
Chubb
US Army
Deloitte
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot